Accessibility Menu
Convatec Group Plc logo

Convatec Group Plc(OTC) CNVVY

Current Price$11.70
Market Cap$5.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)+8%
5 Year-12%
1 Year-11%
1 Month+7%
Convatec Group Plc last closing stock price
MetricPriceDate
Last closeUSD 11.702026-07-24
Convatec Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.95%USD 11.592026-07-17
1 month+7.14%USD 10.922026-06-24
3 month-2.5%USD 12.002026-04-24
Year to date-8.99%USD 12.862025-12-31
1 year-11.46%USD 13.212025-07-24
3 year+12.62%USD 10.392023-07-20
5 year-11.64%USD 13.242021-07-23
Since inception+7.83%USD 10.852017-01-26

Convatec Group Plc Financials at a Glance

Market Cap

$5.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.72B

Net Income (TTM)

$364.11M

EPS (TTM)

$0.34

P/E Ratio

34.08

Dividend

$0.29

Beta (Volatility)

0.29 (Low)

Price

$11.70

Volume

16,448

Open

$11.41

Previous Close

$11.70

Daily Range

$11.41 - $11.70

52-Week Range

$10.45 - $14.09

Estimated Earnings Date

Aug 4, 2026

CNVVY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Convatec Group Plc

ConvaTec Group Plc operates as a global medical technology enterprise, specializing in the development, manufacturing, and distribution of a wide range of healthcare products. The company focuses on advanced wound care, skin protection solutions, and comprehensive ostomy care, serving both hospital and home healthcare markets.

Products and Services
  • Advanced wound care and skin protection solutions
  • Comprehensive ostomy care devices and accessories
  • Continence and critical care products for various medical conditions
Growth Outlook
  • Revenue of $1.25 billion in Q4 2025, showing strong demand
  • Consistent gross profit margin around 55% over recent quarters
  • Expansion into new markets expected to drive future growth
Financial Highlights
  • Net income of $69.9 million in Q4 2025, reflecting solid profitability
  • Operating income margin of 17.8% in Q4 2025, indicating operational efficiency
  • Dividend yield of 2.57% TTM, appealing for income-focused investors
ConvaTec Group Plc has established itself as a key player in the medical technology sector, with a diverse product portfolio that addresses critical healthcare needs. The company's focus on innovation and quality positions it well for future growth, particularly as it expands into new markets. Recent financial performance highlights a robust revenue stream and profitability, making it an attractive option for potential investors. The consistent gross profit margins and operational efficiency further underscore the company's strong market position. With a commitment to enhancing patient care through advanced medical solutions, ConvaTec is poised for continued success in the evolving healthcare landscape.
AI Generated • Jun 25, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,910

CEO

Jonathan Peter Mason, MBA

Website

www.convatec.com

Headquarters

London, GL W2 6LG, GB

CNVVY Financials

Key Financial Metrics (TTM)

Gross Margin

55.76%

Operating Margin

16.51%

Net Income Margin

7.17%

Return on Equity

10.53%

Return on Capital

13.44%

Return on Assets

4.64%

Earnings Yield

2.93%

Dividend Yield

2.47%

Payout Ratio

78.06%

Stock Overview

Market Cap

$5.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

487.35M

Volume

16.45K

Avg. Volume

31.86K

Financials (TTM)

Gross Profit

$2.62B

Operating Income

$735.99M

EBITDA

$1.17B

Operating Cash Flow

$859.32M

Capital Expenditure

-$242.47M

Free Cash Flow

$616.84M

Cash & ST Invst.

$75.00M

Total Debt

$1.52B

Convatec Group Plc Performance Analysis

Convatec Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,071,220,9781.6%
20232023-12-31USD 2,150,704,0963.8%
20242024-12-31USD 2,290,163,2706.5%
20252025-12-31USD 2,444,699,6286.7%
Convatec Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-303.3%
Q42024-12-315.7%
Q22025-06-300.3%
Q42025-12-316.3%
Convatec Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.12-46.9%
20232023-12-31USD 0.25106.9%
20242024-12-31USD 0.3745.4%
20252025-12-31USD 0.34-6.9%
Convatec Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-309.1%
Q42024-12-3141.1%
Q22025-06-30-5.4%
Q42025-12-31-31.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$1.25B

+16.3%

Gross Profit

$700.16M

+19.3%

Gross Margin

55.82%

N/A

Market Cap

$5.70BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$522.64K

N/A

Employees

10,910

N/A

Net Income

$69.94M

-5.5%

EBITDA

$351.07M

+51.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$75.00M

-31.9%

Total Debt

$1.52B

+15.7%

Accounts Receivable

$439.00M

+42.2%

Inventory

$416.00M

+5.0%

Long Term Debt

$1.49B

+15.5%

Short Term Debt

$26.00M

+25.6%

Return on Assets

4.64%

N/A

Return on Invested Capital

12.75%

N/A

Free Cash Flow

$246.50M

+15.8%

Operating Cash Flow

$311.50M

+10.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SSMXYSysmex Corporation
$9.29+1.53%
SHPMYShanghai Pharmaceuticals Holding Co., Ltd
$7.34+0.00%
GNGBYGetinge AB (publ)
$23.62+0.88%
SKHCFSonic Healthcare Limited
$13.80+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$92.32-0.08%
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%

Questions About CNVVY

What is the current price of Convatec Group Plc?

Convatec Group Plc is trading at $11.70 per share.

What is the 52-week range for Convatec Group Plc?

Over the past 52 weeks, Convatec Group Plc has traded between $10.45 and $14.09.

How much debt does Convatec Group Plc have?

As of the most recent reporting period, Convatec Group Plc reported total debt of $1.52B.

How much cash does Convatec Group Plc have on hand?

Convatec Group Plc reported $75.00M in cash and cash equivalents in its most recent financial results.

What is Convatec Group Plc’s dividend yield?

Convatec Group Plc currently has a dividend yield of 2.47%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services